摘要
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic syndrome, which is insulin resistant, pancreatic dysfunction of beta cells, chronic inflammation, and oxidative stress, culminating in disastrous microvascular and macrovascular complications. Although there is a variety of antidiabetic medications, long-term treatment is frequently constrained due to adverse responses, progressive failure and poor management of subsequent complications. Plant-derived bioactive compounds have been of special interest in recent years as a therapeutic option because of their multitargets, safety, and pharmacological properties as illustrated in experimental research. The review aims to highlight the molecular pathways involved in the antidiabetic actions of plant bioactives, such as the regulation of insulin signalling pathways (IRS-1/PI3K/Akt/GLUT4), activation of the AMP-activated protein kinase (AMPK), the pro-inflammatory mediators, e.g., NF-kB, TNF-a and IL-6. Moreover, the protective effects of such bioactives in ameliorating diabetic complications which include nephropathy, neuropathy, cardiovascular dysfunction and compromised wound healing are discussed using evidence of in vitro and in vivo experimental models. Even though the preclinical evidence is encouraging, there are shortcomings such as standardization, mechanistic validation, and poor clinical translation, which are a challenge. Further studies must focus on molecular studies, standardized extract preparations, and properly structured clinical trials in order to foster application of plant-based extracts in control of diabetes.